4.6 Article

Toward therapeutic electrophysiology: beta-band suppression as a biomarker in chronic local field potential recordings

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Modulation of beta bursts in subthalamic sensorimotor circuits predicts improvement in bradykinesia

Yasmine M. Kehnemouyi et al.

Summary: There is currently no biomarker available for clinicians to adjust chronic therapies for Parkinson's disease. Studies suggest that beta oscillopathy in the subthalamic nucleus is related to motor symptoms in Parkinson's disease, and deep brain stimulation may improve symptoms by modulating this activity.
Review Clinical Neurology

Technology of deep brain stimulation: current status and future directions

Joachim K. Krauss et al.

Summary: Deep brain stimulation (DBS) is a neurosurgical procedure that allows targeted circuit-based neuromodulation and is now commonly used for the treatment of movement disorders such as Parkinson's disease, tremor, and dystonia. Advances in engineering and imaging technologies are expected to enhance the efficacy and tolerability of DBS procedures in the future.

NATURE REVIEWS NEUROLOGY (2021)

Article Clinical Neurology

Subthalamic beta band suppression reflects effective neuromodulation in chronic recordings

Lucia K. Feldmann et al.

Summary: This study aimed to assess the stimulation-induced modulation of beta-band activity and clinical symptoms in a Parkinson's disease patient using a novel implantable pulse generator. Results showed that an increase in stimulation amplitude led to decreased beta oscillatory activity and improvement in bradykinesia. The correlation between low beta-band activity and bradykinesia highlights the potential of beta activity as a reliable biomarker for motor improvement in Parkinson's disease.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

Lack of progression of beta dynamics after long-term subthalamic neurostimulation

Ross W. Anderson et al.

Summary: Longitudinal study on patients with Parkinson's disease undergoing medication washout and bilateral subthalamic nucleus deep brain stimulation (STN DBS) showed that beta oscillopathy did not substantially progress following combined STN DBS plus medication in moderate to advanced stages of the disease.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Neurosciences

Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease

Tommaso Bocci et al.

Summary: This study found that closed-loop adaptive deep brain stimulation (aDBS) has better effects on motor symptoms in patients with Parkinson's Disease compared to conventional deep brain stimulation (cDBS), with lower electrical energy delivered to the tissues.

NPJ PARKINSONS DISEASE (2021)

Article Neurosciences

Risk of Infection after Deep Brain Stimulation Surgery with Externalization and Local-Field Potential Recordings: Twelve-Year Experience from a Single Institution

Lucia K. Feldmann et al.

Summary: This study demonstrates that DBS is a surgical procedure with a low risk of infection in a large patient cohort. Importantly, it shows that LFP recordings do not have a significant effect on the incidence of infections in patients with externalization. With a representative cohort of more than 380 patients participating in LFP-recordings, this underlines LFP as a safe method in research and supports further use of this method, for example, for the development of adaptive stimulation protocols.

STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2021)

Article Neurosciences

Chronic Sensing of Subthalamic Local Field Potentials: Comparison of First and Second Generation Implantable Bidirectional Systems Within a Single Subject

Daniel D. Cummins et al.

Summary: This study compared the sensing capabilities of the first-generation Medtronic PC + S and second-generation Percept PC neurostimulators in a single patient with Parkinson's disease. The results showed that the Percept PC had improved ability to sense local field potential signals during active stimulation compared to the PC + S, which was limited by artifact interference. The advancement in implantable neurostimulator technology between the first and second generation devices demonstrates the potential for further exploration into the neurophysiology of movement disorders and the clinical implementation of adaptive algorithms.

FRONTIERS IN NEUROSCIENCE (2021)

Article Clinical Neurology

Modulation of beta bursts in subthalamic sensorimotor circuits predicts improvement in bradykinesia

Yasmine M. Kehnemouyi et al.

Summary: It has been found that improvements in bradykinesia in Parkinson's disease patients undergoing deep brain stimulation are linked to a reduction in beta oscillopathy in the sensorimotor region. The degree of improvement correlates with the reduction in beta power and burst durations, as well as the volume of tissue modulated in the subthalamic nucleus. These findings suggest that beta oscillopathy combined with lead location could potentially serve as a marker for real-time feedback to adjust clinical settings or drive closed-loop deep brain stimulation.
Article Clinical Neurology

Acute effects of adaptive Deep Brain Stimulation in Parkinson's disease

Dan Pina-Fuentes et al.

BRAIN STIMULATION (2020)

Article Clinical Neurology

Dual threshold neural closed loop deep brain stimulation in Parkinson disease patients

A. Velisar et al.

BRAIN STIMULATION (2019)

Article Clinical Neurology

Eight-hours adaptive deep brain stimulation in patients with Parkinson disease

Mattia Arlotti et al.

NEUROLOGY (2018)

Article Engineering, Biomedical

A Chronically Implantable Neural Coprocessor for Investigating the Treatment of Neurological Disorders

Scott Stanslaski et al.

IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS (2018)

Article Clinical Neurology

Subthalamic Beta Dynamics Mirror Parkinsonian Bradykinesia Months After Neurostimulator Implantation

Leon Amadeus Steiner et al.

MOVEMENT DISORDERS (2017)

Article Clinical Neurology

Connectivity Predicts Deep Brain Stimulation Outcome in Parkinson Disease

Andreas Horn et al.

ANNALS OF NEUROLOGY (2017)

Article Clinical Neurology

Bilateral adaptive deep brain stimulation is effective in Parkinson's disease

Simon Little et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Medicine, Research & Experimental

Tremor Reduction by Deep Brain Stimulation Is Associated With Gamma Power Suppression in Parkinson's Disease

Martijn Beudel et al.

NEUROMODULATION (2015)

Article Neurosciences

High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

Jon B. Toledo et al.

NEUROBIOLOGY OF DISEASE (2014)

Article Clinical Neurology

Adaptive Deep Brain Stimulation in Advanced Parkinson Disease

Simon Little et al.

ANNALS OF NEUROLOGY (2013)

Article Neurosciences

Beta band stability over time correlates with Parkinsonian rigidity and bradykinesia

S. Little et al.

EXPERIMENTAL NEUROLOGY (2012)

Article Engineering, Biomedical

Design and Validation of a Fully Implantable, Chronic, Closed-Loop Neuromodulation Device With Concurrent Sensing and Stimulation

Scott Stanslaski et al.

IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2012)

Article Engineering, Biomedical

A chronic generalized bi-directional brain-machine interface

A. G. Rouse et al.

JOURNAL OF NEURAL ENGINEERING (2011)

Article Clinical Neurology

Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients

A. Eusebio et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Article Neurosciences

Bilateral symmetry and coherence of subthalamic nuclei beta band activity in Parkinson's disease

Camille de Solages et al.

EXPERIMENTAL NEUROLOGY (2010)

Article Clinical Neurology

How do parkinsonian signs return after discontinuation of subthalamic DBS?

P Temperli et al.

NEUROLOGY (2003)